Corticosteroids for RH isoimmunization

ORAL PREDNISOLONE VERSUS INTRAUTERINE TRANSFUSION IN ISOIMMUNIZED PREGNANT FEMALES WITH RH INCOMBATIBILITY

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR201707002409642

Enrollment

Registered

2017-07-06

Start date

2017-07-06

Completion date

Unknown

Last updated

2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pregnancy and Childbirth Rh isoimmunization, immune hydrops fetalis

Interventions

predisolone tablets

O negative RBCs

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Pregnant females Rh negative blood group Indirect Coomb's test positive of Anti-Rh antibodies titre above 1/16

Exclusion criteria

Exclusion criteria: Cases with established hydrops fetalis

Design outcomes

Primary

Measure	Time frame
prevention of fetal anemia;Lowering of anti-Rh antibodies titre;Prevention of fetal anemia and hydrops fetalis	—

Secondary

Measure	Time frame
Delivery of a healthy fetus gestation	—

Countries

Egypt

Contacts

Public ContactTamer Abdel Dayem

Associate professor

tmdaeim@gmail.com0020126720766

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026